| IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO DE Reuss, Y Mamatjan, D Schrimpf, D Capper, V Hovestadt, A Kratz, ... Acta neuropathologica 129, 867-873, 2015 | 314 | 2015 |
| DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ... Neuro-oncology 21 (7), 901-910, 2019 | 160 | 2019 |
| A clinically applicable integrative molecular classification of meningiomas F Nassiri, J Liu, V Patil, Y Mamatjan, JZ Wang, R Hugh-White, AM Macklin, ... Nature 597 (7874), 119-125, 2021 | 147 | 2021 |
| Adjacent stimulation and measurement patterns considered harmful A Adler, PO Gaggero, Y Maimaitijiang Physiological measurement 32 (7), 731, 2011 | 145 | 2011 |
| The genomic landscape of schwannoma S Agnihotri, S Jalali, MR Wilson, A Danesh, M Li, G Klironomos, ... Nature genetics 48 (11), 1339-1348, 2016 | 118 | 2016 |
| Imaging and diagnostic advances for intracranial meningiomas RY Huang, WL Bi, B Griffith, TJ Kaufmann, C la Fougère, NO Schmidt, ... Neuro-oncology 21 (Supplement_1), i44-i61, 2019 | 109 | 2019 |
| Advances in multidisciplinary therapy for meningiomas PK Brastianos, E Galanis, N Butowski, JW Chan, IF Dunn, R Goldbrunner, ... Neuro-oncology 21 (Supplement_1), i18-i31, 2019 | 103 | 2019 |
| Molecular and translational advances in meningiomas S Suppiah, F Nassiri, WL Bi, IF Dunn, CO Hanemann, CM Horbinski, ... Neuro-oncology 21 (Supplement_1), i4-i17, 2019 | 95 | 2019 |
| Evaluation of EIT system performance M Yasin, S Böhm, PO Gaggero, A Adler Physiological measurement 32 (7), 851, 2011 | 75 | 2011 |
| Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas S Agnihotri, S Suppiah, PD Tonge, S Jalali, A Danesh, JP Bruce, ... Nature communications 8 (1), 186, 2017 | 74 | 2017 |
| Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life F Nassiri, B Price, A Shehab, K Au, MD Cusimano, MD Jenkinson, ... Neuro-oncology 21 (Supplement_1), i32-i43, 2019 | 70 | 2019 |
| CIC protein instability contributes to tumorigenesis in glioblastoma S Bunda, P Heir, J Metcalf, ASC Li, S Agnihotri, S Pusch, M Yasin, M Li, ... Nature communications 10 (1), 661, 2019 | 65 | 2019 |
| Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma CellsAzoles Inhibit HK2 and GBM Growth S Agnihotri, S Mansouri, K Burrell, M Li, Y Mamatjan, J Liu, R Nejad, ... Clinical Cancer Research 25 (2), 844-855, 2019 | 50 | 2019 |
| The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care S Karimi, JA Zuccato, Y Mamatjan, S Mansouri, S Suppiah, F Nassiri, ... Clinical epigenetics 11 (1), 1-10, 2019 | 47 | 2019 |
| Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas K Fukuoka, Y Mamatjan, R Tatevossian, M Zapotocky, S Ryall, ... Neuro-oncology 22 (10), 1474-1483, 2020 | 27 | 2020 |
| TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy Q Wei, O Singh, C Ekinci, J Gill, M Li, Y Mamatjan, S Karimi, S Bunda, ... Acta neuropathologica communications 9, 1-19, 2021 | 25 | 2021 |
| An experimental clinical evaluation of EIT imaging with ℓ1 data and image norms Y Mamatjan, A Borsic, D Gürsoy, A Adler Physiological measurement 34 (9), 1027, 2013 | 24 | 2013 |
| Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics Z Wu, Z Abdullaev, D Pratt, HJ Chung, S Skarshaug, V Zgonc, C Perry, ... Neuro-oncology 24 (4), 571-581, 2022 | 22 | 2022 |
| Evaluation and real-time monitoring of data quality in electrical impedance tomography Y Mamatjan, B Grychtol, P Gaggero, J Justiz, VM Koch, A Adler IEEE Transactions on Medical Imaging 32 (11), 1997-2005, 2013 | 22 | 2013 |
| International Consortium on Meningiomas. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical … F Nassiri, Y Mamatjan, S Suppiah Neuro Oncol 21 (7), 901-910, 2019 | 21 | 2019 |
Kenneth AldapeNational Cancer InstituteVerified email at nih.gov
